ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 16.4050 ↓ -0.99%
[as on 13 February, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option and its peers as on 13 February, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option -3.56% -0.99% 1.88% -2.82% -6.8% -1.09% 20.58%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -3.44% -1.05% 0.6% -1.55% -4.72% 1.29% 13.92% 16.69% 16.2% 16.86%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -1.92% -0.96% -0.17% -0.93% -1.11% 10.24% 14.69% 12.18% 14.56% 14.93%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH -0.71% -1.01% 1.53% -0.77% -3.47% 3.79% 25.54% 16.87% 21.41% 13.46%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -1.43% -1.21% -0.35% 1.76% -1.33% 8.93% 22.39% 21.1% 21.08% 18.32%
SBI PSU Fund - DIRECT PLAN - GROWTH 5.59% -1.19% 1.43% 5.81% 6.15% 30.1% 35.14% 29.88% 23.35% 18.01%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------6.9%35.22%44.46%-9.08%

Discrete returns (monthly)

MonthApr 2025May 2025Jun 2025Jul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026
Returns3.46%0.19%3.38%2.48%-1.75%-1.48%2.29%-1.03%-2.44%-6.81%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns-6.28%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.31% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.69%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.96%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.97%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.35%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.71%
Torrent Pharmaceuticals LimitedTORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.51%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology4.43%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.98%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology3.70%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services3.62%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.07%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology3.04%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.95%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology2.82%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology2.57%
Wockhardt LimitedWOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology2.27%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.20%
Healthcare Global Enterprises LimitedHCG (INE075I01017)Healthcare Services1.77%
Glenmark Pharmaceuticals LimitedGLENMARK (INE935A01035)Pharmaceuticals & Biotechnology1.73%
Laurus Labs LimitedLAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology1.69%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.53%
FDC LimitedFDC (INE258B01022)Pharmaceuticals & Biotechnology1.40%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals1.35%
SBI Life Insurance Company LimitedSBILIFE (INE123W01016)Insurance1.25%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.23%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology1.22%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.21%
Onesource Specialty Pharma LimitedONESOURCE (INE013P01021)Pharmaceuticals & Biotechnology1.19%
Rainbow Childrens Medicare LimitedRAINBOW (INE961O01016)Healthcare Services1.19%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology1.13%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology1.13%
Standard Glass Lining Technology LtdSGLTL (INE0M4D01010)Industrial Manufacturing1.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology0.99%
Poly Medicure LimitedPOLYMED (INE205C01021)Healthcare Equipment & Supplies0.93%
Caplin Point Laboratories LimitedCAPLIPOINT (INE475E01026)Pharmaceuticals & Biotechnology0.86%
Supriya Lifescience LimitedSUPRIYA (INE07RO01027)Pharmaceuticals & Biotechnology0.85%
Linde India LimitedLINDEINDIA (INE473A01011)Chemicals & Petrochemicals0.81%
Shilpa Medicare LimitedSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology0.75%
UPL LimitedUPL (INE628A01036)Fertilizers & Agrochemicals0.72%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology0.70%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.48%

Debt

NameRatingWeight %
Portfolio data is as on date 31 October, 2025

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV
13 February, 202616.4050
12 February, 202616.5685
11 February, 202616.6429
10 February, 202616.4199
9 February, 202616.3693
6 February, 202616.1021
5 February, 202616.2038
4 February, 202616.2555
3 February, 202616.2910
2 February, 202615.8515
30 January, 202615.9842
29 January, 202615.7876
28 January, 202615.9559
27 January, 202615.9292
23 January, 202616.0077
22 January, 202616.2044
21 January, 202616.0343
20 January, 202616.1657
19 January, 202616.5520
16 January, 202616.6807
14 January, 202616.8414
13 January, 202616.8812
12 January, 202616.8911
9 January, 202617.0027
8 January, 202617.1990
7 January, 202617.4366
6 January, 202617.3186
5 January, 202617.0841
2 January, 202617.1355
1 January, 202617.0101

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 16.4050 as on 13 February, 2026.
  • What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -3.56% as on 13 February, 2026.
  • What are 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 1 year returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are -1.09% as on 13 February, 2026.
  • What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option?
    The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 20.58% as on 13 February, 2026.